Picture of OptimizeRx logo

OPRX — OptimizeRx News Story

0.000.00%
us flag iconLast trade - 00:00
TechnologyAdventurousSmall CapSuper Stock

Optimizerx Corp Expected To Post Earnings Of 7 Cents A Share: Earnings Preview

* OPTIMIZERx Corp  OPRX.OQ   OPRX.O  is expected to show a rise
in quarterly revenue when it reports results on August 4. 
* The Rochester, Michigan-based company is expected to report 
 a 41.8% increase in revenue to $12.45 million from $8.78
million a year ago, according to the mean estimate from 5
analysts, based on Refinitiv data. 
​* Refinitiv's mean analyst estimate for OPTIMIZERx Corp is for
earnings of 7 cents per share. For the same quarter last year,
the company reported earnings of 2 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for OPTIMIZERx Corp
is $73​, about 24.5% above​ its last closing price
of $55.11. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Mar. 31 2021  -0.01       0.01       0.03      Beat    275
 Dec. 31 2020  0.16        0.16       0.16      Met     3.2
 Sep. 30 2020  0.04        0.04       0.07      Beat    75​
 Jun. 30 2020  -0.03       -0.03      0.02      Beat    166.7
 Mar.          -0.03​      -0.03      -0.06     Missed  -100​
 31​ 2020​                                              
 Dec. 31 2019  0.00        0.01       -0.03     Missed  -700​
 Sep. 30 2019  0.08        0.08       -0.05     Missed  -164.5
 Jun. 30 2019  0.08        0.08       0.09      Beat    16.1
 This summary was machine generated August 2 at 21:33 GMT.  All
figures in US dollars unless otherwise stated

Recent news on OptimizeRx

See all news